Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
of white blood cell, impact cancer immunotherapy. Immunotherapies like immune checkpoint inhibitors (ICIs) have revolutionised cancer treatment, but resistance remains a challenge. The TUNIC project will
-
intensive research, effective therapies remain scarce and the prognosis for this patient group is poor. Although immunotherapy is promising for various types of cancer, patients with peritoneal metastases
-
to develop better immunotherapy approaches. You will be working in a stimulating, multi-disciplinary research environment with international collaborations. Are you willing to take on the challenge
-
MCC gifts and collaborations, including relationships with the Ludwig Foundation, the Parker Institute for Cancer Immunotherapy, the Weill Family Foundation and other donors. Manages vendor contracts
-
or Biosketch Brief statement of research interests (<300 words) Contact information for three references Department website: https://icahn.mssm.edu/about/departments-offices/immunology-immunotherapy Laboratory
-
Cancer Center as well as any non-oncology infusion needs of patients at UCSF. The treatments include but are not limited to chemotherapy, biotherapy, immunotherapy, blood transfusions, hydration and
-
University of North Carolina at Chapel Hill | Chapel Hill, North Carolina | United States | about 17 hours ago
, as articulated in the School’s Strategic Plan (https://pharmacy.unc.edu/about/oe/strategic-plan/). Our Vision is to be the global leader in pharmacy and pharmaceutical sciences. Our Mission is to
-
, the person should be able to carry out the laboratory techniques such as Western blotting, PCR, RT-PCR; should be conversant with tissue culture techniques. Being an immunology/immunotherapy lab, majority
-
Job Description UW Medical Center - Montlake has an outstanding leadership opportunity for an Assistant Nurse Manager (RN3) to join our Medical Oncology / Blood Marrow Transplant / Immunotherapy
-
radiobiological mechanisms. By integrating radiopharmaceutical science, immunotherapy, and translational oncology, this project aims to develop a robust combination therapy platform for OC and TNBC which can help